Project Grant R01AG083373
- This $2,991,725 Project Grant award, provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports research into the role of reactive oxygen species as modulators of lifespan and age-related diseases. The 4-year project, which commenced on September 1, 2025, aims to investigate a novel longevity paradigm in C. elegans that is triggered by early-life oxidative stress and mediated by changes in the epigenetic landscape. The research will examine the conserved mechanisms...
- This $147,486 Project Grant awarded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) supports research to investigate the role of chaperone-mediated autophagy (CMA) in cellular senescence and its contribution to aging. The research aims to understand: 1) if CMA activity changes upon induction of senescence, 2) if CMA modulates senescence kinetics and by what mechanism(s), 3) if CMA is required for senescent cell clearance, and 4) if restoring CMA activity...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate how aging produces ultrastructural alterations to neuronal autophagy, which is critical for maintaining neuronal homeostasis and function. The $429,000 award to the University of Texas Health Science Center at Houston will be used to accomplish two specific aims over the 2-year project period starting January 1, 2025: Compare the ultrastructural features of axonal autophagic...
- This Project Grant award from the National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), provides $871,093 to the Sloan-Kettering Institute for Cancer Research to elucidate novel mechanisms underlying the regulation of the transcription factor EB (TFEB) and the autophagy-lysosomal pathway, and to investigate their therapeutic potential as mechanism-based treatments for Alzheimer's disease. The research aims to delineate how the protein phosphatases...
- This Project Grant award, titled "Investigating TFEB as a Critical Node to Improve Proteostatic Maintenance and Skeletal Muscle Function with Age", is funded by the National Institute on Aging (CFDA 93.866 - Aging Research). The $405,171 award to the Oklahoma Medical Research Foundation (OMRF) aims to determine if transcription factor EB (TFEB) functions as a critical node to improve maintenance and recovery of skeletal muscle mass and function in aged mice with sarcopenia and disuse...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,208,503.00 to Cornell University to conduct research on the role of autophagy in cellular aging. The project, titled "System-wide and Mechanistic Deconvolution of Autophagy in Cellular Aging", aims to systematically investigate how different forms of autophagy influence cellular aging processes, with a focus on understanding how modulating selective autophagy pathways such...
- This Project Grant award of $506,404.00 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to investigate mechanisms of local and global epigenetic changes that drive senescence and aging-associated phenotypes. Key research objectives include: Examining how enhancers are rewired during senescence and aging, focusing on large enhancer communities or "cliques" and identifying transcription factors that drive their formation....
- This $1,039,863 National Institutes of Health National Institute on Aging project grant funds research at Harvard Medical School to reverse engineer the process of cellular senescence. The research will use new microscopy techniques to observe cell size changes and correlate protein expression and phosphorylation with senescence markers as cells transition from normal to senescent states in vitro and in vivo in young and aged mice. The same induction-maturation-death lifecycle will be studied...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,359,000.00 to Baylor College of Medicine to conduct research on age-associated cellular and molecular adaptations that enable whole-organism rejuvenation in the highly regenerative flatworm Schmidtea mediterranea. The research aims to (1) determine how age-associated damage manifests in asexual planaria throughout their lifecycle...
- This $451,000 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund research by The University of Texas Southwestern Medical Center to investigate the role of the p38 MAPK signaling pathway in regulating lysosome function and tissue integrity during development and aging. The key goals of this 2-year project are to: 1) define the p38 MAPK interactome required for lysosome regeneration, 2) reveal tissue and stage-specific functions of p38 MAPK...
HORMETIC REGULATION OF AUTOPHAGY IN AGING - PROJECT SUMMARY AUTOPHAGY DEGRADES CYTOSOLIC MATERIAL, SUCH AS AGGREGATED PROTEINS, VIA THE FORMATION OF AUTOPHAGOSOMES THAT FUSE WITH LYSOSOMES FOR DEGRADATION AND IS IMPORTANT IN THE ADAPTATION TO METABOLIC AND CYTOTOXIC STRESSORS. AUTOPHAGY HAS BEEN SHOWN TO DECLINE WITH AGE AND IS TIGHTLY LINKED TO AGE-RELATED DISEASES, THUS ITS STUDY IS IMPORTANT FOR DEVELOPING FUTURE STRATEGIES TO MAINTAIN HOMEOSTASIS AND PROMOTE HUMAN HEALTH. I HAVE FOUND THAT AUTOPHAGY IS INDUCED IN C. ELEGANS UPON A SHORT EXPOSURE TO A HEAT SHOCK EARLY IN LIFE. SUCH A HEAT SHOCK LEADS TO ORGANISMAL BENEFITS INCLUDING LONGEVITY, A CONSERVED PHENOMENON CALLED HORMESIS. AUTOPHAGY GENES ARE REQUIRED FOR THESE HEAT SHOCK-INDUCED BENEFITS, INDICATING THAT AUTOPHAGY IS A CRITICAL MECHANISM UNDERLYING HORMETIC STRESS RESPONSES. I HAVE IMPLICATED TWO CONSERVED TRANSCRIPTION FACTORS, THE HELIX-LOOP-HELIX TRANSCRIPTION FACTOR HLH-30, AN ORTHOLOG OF MAMMALIAN TRANSCRIPTION FACTOR EB (TFEB), AND HSF- 1 IN REGULATING AUTOPHAGY INDUCTION UPON HS. IT HOWEVER REMAINS UNCLEAR WHEN AND WHERE AUTOPHAGY IS REQUIRED TO MANIFEST LONG-TERM ORGANISMAL BENEFITS. WHILE I HAVE SHOWN THAT SPECIFIC AUTOPHAGY GENES RETAIN ELEVATED TRANSCRIPT LEVELS FOR DAYS, THE TISSUE-SPECIFIC AND POTENTIAL LONG-TERM TRANSCRIPTIONAL SHIFTS INDUCED BY HS, THAT COULD UNDERLIE THE HORMETIC BENEFITS, ARE UNKNOWN. UNDERSTANDING THE EFFECTS OF HEAT SHOCK ON AUTOPHAGY, BOTH IN THE SHORT-TERM (I.E., IMMEDIATE RESPONSE) AS WELL AS IN THE LONG-TERM (I.E., SUSTAINED CHANGES), IS PARAMOUNT FOR DEVELOPING NEW STRATEGIES, SUCH AS THE CONCEPT OF HEAT THERAPY, TO IMPROVE AUTOPHAGY DURING AGING AND IN DISEASES WITH DYSREGULATED AUTOPHAGY. THEREFORE, I HERE PROPOSE TO ANALYZE THE SPATIO-TEMPORAL REQUIREMENT FOR THE AUTOPHAGY-REGULATING TRANSCRIPTION FACTORS HLH-30/TFEB AND HSF-1 FOR HEAT-INDUCED ADAPTATIONS AND ANALYZE THE CELL-SPECIFIC TRANSCRIPTIONAL CHANGES THAT ARE INDUCED BY HS AND SUSTAINED OVER TIME. THE ABILITY TO MOUNT A BENEFICIAL HORMETIC RESPONSE DECLINES WITH AGE AND IS ACCOMPANIED BY REDUCED FUNCTION OF HLH-30/TFEB WHICH IS AMELIORATED BY A HORMETIC HS. HS THUS INDUCES SUSTAINED CHANGES THAT AFFECT HLH-30/TFEB FUNCTION. CONTROLLING THE PROLONGED ACTIVATION OF AUTOPHAGY, FOR INSTANCE VIA TRANSCRIPTIONAL REGULATION, COULD BE AN IMPORTANT WAY OF MANIPULATING AUTOPHAGY, WHICH IN TURN COULD BENEFIT ORGANISMAL FITNESS. HENCE, I AM PROPOSING TO INVESTIGATE HOW THE AUTOPHAGY REGULATOR HLH-30/TFEB IS REGULATED BY HEAT SHOCK AND AGE AND TO IDENTIFY NEW REGULATORS OF HLH-30/TFEB, THAT WILL BE VALIDATED FOR CONSERVATION IN HUMAN DERMAL FIBROBLASTS. UNDERSTANDING THE REGULATORY MECHANISMS BY WHICH AUTOPHAGY ENSURES CYTOPROTECTIVE EFFECTS IN VIVO USING MULTI-CELLULAR ORGANISMS LIKE C. ELEGANS ADDRESSES SIGNIFICANT GAPS IN OUR UNDERSTANDING OF THE TEMPORAL AND SPATIAL DYNAMICS OF HS-INDUCED AUTOPHAGY, CELL-SPECIFIC TRANSCRIPTIONAL RESPONSES TO HS, AND REGULATORY MECHANISMS OF TRANSCRIPTION FACTORS WITH HS AND AGE. THE IMPACT OF THESE INSIGHTS COULD RESHAPE THERAPEUTIC APPROACHES, OFFERING MORE PRECISE INTERVENTIONS FOR DISEASES WITH DEREGULATED AUTOPHAGY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $574.9k | 6/27/25 | ||
| Not listed | $586.6k | 7/1/24 |